Progressive Lung Consolidation in HIV Amidst the COVID-19 Pandemic: Evaluating Probable Cytomegalovirus Pneumonia and the Importance of Early Empirical Treatment

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 8; p. e65921
• Main Authors: Krishnasamy Naido, Sargunann Naidu, Mano Geran, Suria, Adam Khan, Nashriq Khan, An, Noralfazita
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 01.08.2024; Cureus
• Subjects: Acquired immune deficiency syndrome; AIDS; Antibiotics; Antigens; Antiviral drugs; Bacterial infections; Biopsy; Colonoscopy; Coronaviruses; COVID-19; Cysts; Cytomegalovirus; Drug therapy; Dyspnea; Fever; Hemoptysis; HIV; HIV/AIDS; Human immunodeficiency virus; Infections; Infectious Disease; Inflammatory bowel disease; Pathogens; Patients; Pneumonia; Pulmonary embolisms; Pulmonology; Tuberculosis; empirical antiviral therapy; covid-19; non-resolving pneumonia; cytomegalovirus pneumonia; hiv aids
• DOI: 10.7759/cureus.65921
• ISSN: 2168-8184

We present the case of a young male who was diagnosed with HIV in 2012. However, his initiation of antiretroviral therapy (ART) was delayed until 2018 due to issues related to his acceptance and acknowledgment of the disease. In April 2021, the patient presented with hemoptysis, shortness of breath, and constitutional symptoms. Initial extensive workup for tuberculosis (TB) and other respiratory pathogens returned negative. Despite this, he was treated for smear-negative pulmonary TB and pneumocystis pneumonia (PCP) and was subsequently discharged. He then had recurrent hospital admissions due to worsening respiratory symptoms, with short intervals between recovery and recurrence. Each admission saw an increase in his oxygen requirements. Throughout these hospitalizations, tests for coronavirus disease 2019 (COVID-19) were consistently negative. TB and PCP treatment continued throughout his admissions. Despite various treatments, his condition continued to deteriorate. A DNA polymerase chain reaction (DNA PCR) test for cytomegalovirus (CMV) was eventually conducted. Unfortunately, the patient succumbed to progressive respiratory failure, and the CMV DNA PCR returned positive a week after his death. In the era of COVID-19, this case underscores the importance of early diagnosis and timely antiviral treatment.